Clinical and Molecular Evolution of an ALK-Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors

ALK inhibitor
DOI: 10.1200/po.22.00547 Publication Date: 2023-03-30T19:59:12Z